Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Tramadol supplied globally from India as psychotropic substance: UN body

      Tramadol supplied globally from India as psychotropic substance: UN body

      Medical Dialogues Bureau29 Feb 2020 2:54 PM IST
      Globally, most of the tramadol, which is not an internationally controlled substance, that was seized from 2013 to 2017 was reported to have...
      Dr Reddys Laboratories launches generic of Naproxen, Esomeprazole Magnesium Delayed-Release Tablets

      Dr Reddy's Laboratories launches generic of Naproxen, Esomeprazole Magnesium Delayed-Release Tablets

      Medical Dialogues Bureau29 Feb 2020 1:30 PM IST
      Dr Reddy's Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of...
      Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection

      Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection

      Medical Dialogues Bureau29 Feb 2020 11:35 AM IST
      New Delhi: Drug API maker, Biocon has informed that the U.S. Food and Drug Administration (FDA) conducted a Post-Approval and GMP inspection of Small...
      Spanish Pharmaceutical Leader Ferrer Partners with Wellthy Therapeutics

      Spanish Pharmaceutical Leader Ferrer Partners with Wellthy Therapeutics

      Medical Dialogues Bureau29 Feb 2020 10:45 AM IST
      New Delhi: Wellthy Therapeutics DTx solution has emerged global winner at Ferrer's 4 Future Innovation Challenge The Ferrer 4 Future...
      Mylan warns of possible drug shortages, financial hit due to coronavirus

      Mylan warns of possible drug shortages, financial hit due to coronavirus

      Medical Dialogues Bureau29 Feb 2020 9:30 AM IST
      Although heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

      Medical Dialogues Bureau28 Feb 2020 4:26 PM IST
      New Delhi: In the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) has identified 58...
      Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US

      Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US

      Medical Dialogues Bureau28 Feb 2020 2:42 PM IST
      Ryaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray...
      Sanjeev Narula CFO Pfizer Upjohn  appointed as incoming CFO of Viatris

      Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris

      Medical Dialogues Bureau28 Feb 2020 1:45 PM IST
      Viatris is the new company that will result from the planned combination of Mylan and Upjohn
      GeneTex Launches Novel Antibody for pancreatic tumor

      GeneTex Launches Novel Antibody for pancreatic tumor

      Medical Dialogues Bureau28 Feb 2020 9:15 AM IST
      Irvine: GeneTex, a research antibody manufacturing company, has announced the release of a novel recombinant rabbit monoclonal RAS (G12D mutant)...
      Veterinary drug maker Lasa Supergenerics acquires Harishree Aromatics

      Veterinary drug maker Lasa Supergenerics acquires Harishree Aromatics

      Medical Dialogues Bureau28 Feb 2020 9:00 AM IST
      The amalgamation of both the entities stands to extract synergistic benefits, economies of scale, better cash flow management, optimisation of...
      AstraZeneca to sublicense global rights to Movantik

      AstraZeneca to sublicense global rights to Movantik

      Medical Dialogues Bureau28 Feb 2020 9:00 AM IST
      Movantik is a once-daily oral PAMORA approved by the US Food and Drug Administration for the treatment of OIC in adult patients with chronic...
      Members are ready to brace up for any shortages in medical equipment: MTaI

      Members are ready to brace up for any shortages in medical equipment: MTaI

      Medical Dialogues Bureau27 Feb 2020 5:48 PM IST
      New Delhi: Medical Technology Association of India (MTaI), which is an association of leading research-based medical technology companies today said...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok